On June 16, Senate Finance Committee Democrats released an RFI on proposals to lower the cost of prescription drugs. On Aug. 17, AMCP submitted comments in response.
Last year, the Alternatives to PAIN Act was introduced with bipartisan support in the House of Representatives (H.R. 1227) and Senate (S. 475). It aims to ensure appropriate access to non-opioid pain management drugs under Part D of the Medicare program. Of note, this legislation would impose burdensome cost-sharing reductions and utilization management (UM) restrictions on non-opioid pain management medications furnished through the Medicare prescription drug program.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.